The buyback is a modest commitment relative to market cap and does not alter the fundamental outlook. Monitor for acceleration in repurchase pace or completion of the program, which would signal stronger conviction from management. No immediate catalyst for direction.
Price Chart
Executive Summary
Cosmos Health announced the repurchase of 80,000 additional shares at ~$0.2503 per share, bringing total repurchases under its $5M program to ~$831K (4.14M shares). The buyback is a routine capital return activity that does not change the company's fundamentals or financial trajectory, and the $16M market cap and dilutive history make this a modest signal.
Key Financial Metrics
Key Facts
- Repurchased 80,000 shares at an average price of approximately $0.2503 per share.
- Total repurchases under the $5M program are 4,140,000 shares for approximately $831,000.
- The program expires on December 31, 2026.
- Market cap is approximately $16M, making the $831K in buybacks about 5.2% of market cap at current prices.
Financial Impact
Buyback program authorization up to $5M; ~$831K executed so far (16.6% of authorization). Current repurchase represents about 0.1% of outstanding shares added to treasury.
Risk Factors
- Buyback program may not be fully utilized—execution depends on market conditions and management discretion.
- No financial performance data (revenue, earnings) is provided in this release, so the buyback alone does not address fundamental challenges.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3325172 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.2530 | awaiting T+20 | — | $0.2610 (+3.16%) |
Oct 16, 2026 10d ago | SC 13G/A | $0.3250 | awaiting T+20 | — | $0.2610 (−19.69%) |
Oct 9, 2026 17d ago | 8-K | $0.3496 | awaiting T+20 | — | $0.2610 (−25.34%) |
Sep 3, 2026 7w ago | Press Release | $0.2660 $0.4300 | ▼ −61.65% | ▼ −62.77% | $0.2610 (+1.88%) |
Aug 19, 2026 9w ago | Press Release | $0.1930 | awaiting T+20 | — | $0.2610 (−35.23%) |
Jul 20, 2026 14w ago | Press Release | $0.2303 $0.2050 | ▼ −10.99% | ▼ −15.11% | $0.2610 (+13.33%) |
Jul 17, 2026 14w ago | Press Release | $0.2348 $0.2179 | ▼ −7.20% | ▼ −11.64% | $0.2610 (+11.16%) |
Jul 16, 2026 14w ago | Press Release | $0.2807 $0.2065 | ▼ −26.43% | ▼ −30.05% | $0.2610 (−7.02%) |
Jul 15, 2026 14w ago | Press Release | $0.2785 $0.2071 | ▼ −25.64% | ▼ −27.98% | $0.2610 (−6.28%) |
Jul 14, 2026 14w ago | Press Release | $0.3071 $0.2198 | ▼ −28.43% | ▼ −30.92% | $0.2610 (−15.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers